Source Natural Foods and Herbal Supplements Limited (BOM:531398)
130.00
+4.20 (3.34%)
At close: Mar 10, 2026
BOM:531398 Revenue
Source Natural Foods and Herbal Supplements had revenue of 202.96M INR in the quarter ending December 31, 2025, with 94.28% growth. This brings the company's revenue in the last twelve months to 654.13M, up 83.30% year-over-year. In the fiscal year ending March 31, 2025, Source Natural Foods and Herbal Supplements had annual revenue of 449.23M with 64.57% growth.
Revenue (ttm)
654.13M
Revenue Growth
+83.30%
P/S Ratio
1.24
Revenue / Employee
16.35M
Employees
40
Market Cap
809.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 449.23M | 176.27M | 64.57% |
| Mar 31, 2024 | 272.97M | 75.11M | 37.96% |
| Mar 31, 2023 | 197.86M | -17.41M | -8.09% |
| Mar 31, 2022 | 215.27M | -33.53M | -13.48% |
| Mar 31, 2021 | 248.80M | 112.89M | 83.07% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Makers Laboratories | 1.39B |
| Accretion Pharmaceuticals | 826.43M |
| Amwill Health Care | 386.31M |
| Asston Pharmaceuticals | 244.84M |
| Mercury Laboratories | 761.53M |
| Concord Drugs | 512.41M |
| Godavari Drugs | 986.94M |
| Onyx Biotec | 663.87M |